Tag: regulatory capture

While ivermectin and other safe re-purposed drugs are rubbished in most of the legacy media who follow pharmaceutical industry handouts, see the following British Medical Journal investigation

“Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies they are meant to regulate? Maryanne Demasi investigates“